I began a consultancy project commissioned by Cochrane and the Evidence Synthesis Infrastructure Collaborative (ESIC) of the Wellcome Trust. It is an immense privilege to collaborate with fifteen colleagues in influential roles…

I was commissioned to design and deliver an ambitious and rewarding initiative — an “Inclusion by Design” programme aimed at enhancing the research culture at IMBA, the Institute of Molecular Biotechnology at the Vienna BioCenter.

There are major shifts taking place in the world of Equity, Diversity and Inclusion (EDI) globally and in the UK. One such shift, the least perceptible, is also perhaps the most fundamental.